

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 7.70296766 |
| 2 | platelet dense granule organization (GO:0060155) | 5.45628562 |
| 3 | adenosine metabolic process (GO:0046085) | 4.80334555 |
| 4 | sequestering of actin monomers (GO:0042989) | 4.62803833 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.61725001 |
| 6 | behavioral response to nicotine (GO:0035095) | 4.25757436 |
| 7 | DNA deamination (GO:0045006) | 4.12756298 |
| 8 | thrombin receptor signaling pathway (GO:0070493) | 4.06142474 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.01520709 |
| 10 | ATP synthesis coupled proton transport (GO:0015986) | 4.01520709 |
| 11 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.00234352 |
| 12 | proteasome assembly (GO:0043248) | 3.97516013 |
| 13 | protein complex biogenesis (GO:0070271) | 3.73263277 |
| 14 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.71336500 |
| 15 | NADH dehydrogenase complex assembly (GO:0010257) | 3.71336500 |
| 16 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.71336500 |
| 17 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.60517006 |
| 18 | serotonin receptor signaling pathway (GO:0007210) | 3.57490541 |
| 19 | negative regulation of norepinephrine secretion (GO:0010700) | 3.56135816 |
| 20 | electron transport chain (GO:0022900) | 3.54011433 |
| 21 | respiratory electron transport chain (GO:0022904) | 3.51152511 |
| 22 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.49609906 |
| 23 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.46624347 |
| 24 | purine-containing compound salvage (GO:0043101) | 3.33108670 |
| 25 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.32284852 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.26890324 |
| 27 | glycerophospholipid catabolic process (GO:0046475) | 3.26321237 |
| 28 | relaxation of smooth muscle (GO:0044557) | 3.22019314 |
| 29 | coenzyme catabolic process (GO:0009109) | 3.16559790 |
| 30 | blood coagulation, intrinsic pathway (GO:0007597) | 3.14167229 |
| 31 | regulation of cilium movement (GO:0003352) | 3.09851576 |
| 32 | positive regulation of amino acid transport (GO:0051957) | 3.09451886 |
| 33 | hydrogen ion transmembrane transport (GO:1902600) | 3.01573697 |
| 34 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.98304437 |
| 35 | neurofilament cytoskeleton organization (GO:0060052) | 2.91850208 |
| 36 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.91685075 |
| 37 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.91527301 |
| 38 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.89236828 |
| 39 | anterograde synaptic vesicle transport (GO:0048490) | 2.86200826 |
| 40 | proton transport (GO:0015992) | 2.85425194 |
| 41 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.81671040 |
| 42 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.81671040 |
| 43 | hydrogen transport (GO:0006818) | 2.80429089 |
| 44 | oxidative phosphorylation (GO:0006119) | 2.79715260 |
| 45 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.76660247 |
| 46 | regulation of norepinephrine secretion (GO:0014061) | 2.76144341 |
| 47 | inner mitochondrial membrane organization (GO:0007007) | 2.74167706 |
| 48 | negative regulation of telomere maintenance (GO:0032205) | 2.73882507 |
| 49 | artery smooth muscle contraction (GO:0014824) | 2.71602537 |
| 50 | negative regulation of membrane potential (GO:0045837) | 2.71397200 |
| 51 | organelle disassembly (GO:1903008) | 2.70825903 |
| 52 | negative regulation of heart rate (GO:0010459) | 2.70507366 |
| 53 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.68529126 |
| 54 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.66171875 |
| 55 | tonic smooth muscle contraction (GO:0014820) | 2.65936050 |
| 56 | negative regulation of smooth muscle contraction (GO:0045986) | 2.65234641 |
| 57 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.63222986 |
| 58 | positive regulation of prostaglandin secretion (GO:0032308) | 2.62502155 |
| 59 | synaptic transmission, cholinergic (GO:0007271) | 2.61821990 |
| 60 | negative regulation of protein oligomerization (GO:0032460) | 2.59412228 |
| 61 | ribonucleoprotein complex disassembly (GO:0032988) | 2.59030213 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 2.57776770 |
| 63 | amine catabolic process (GO:0009310) | 2.57776770 |
| 64 | chaperone-mediated protein transport (GO:0072321) | 2.57723976 |
| 65 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.56795780 |
| 66 | negative regulation of response to food (GO:0032096) | 2.56459935 |
| 67 | negative regulation of appetite (GO:0032099) | 2.56459935 |
| 68 | base-excision repair, AP site formation (GO:0006285) | 2.53710568 |
| 69 | piRNA metabolic process (GO:0034587) | 2.53218519 |
| 70 | positive regulation of protein homodimerization activity (GO:0090073) | 2.49981356 |
| 71 | purine nucleotide salvage (GO:0032261) | 2.47313480 |
| 72 | regulation of meiosis I (GO:0060631) | 2.45076236 |
| 73 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.44392614 |
| 74 | S-adenosylmethionine metabolic process (GO:0046500) | 2.43689153 |
| 75 | positive regulation of organic acid transport (GO:0032892) | 2.40082685 |
| 76 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.38966465 |
| 77 | inositol phosphate dephosphorylation (GO:0046855) | 2.38966465 |
| 78 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.38733413 |
| 79 | respiratory chain complex IV assembly (GO:0008535) | 2.38566501 |
| 80 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.38248250 |
| 81 | positive regulation of T cell cytokine production (GO:0002726) | 2.38082183 |
| 82 | negative regulation of muscle contraction (GO:0045932) | 2.36261335 |
| 83 | regulation of platelet activation (GO:0010543) | 2.35371347 |
| 84 | inositol phosphate catabolic process (GO:0071545) | 2.34867116 |
| 85 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.33822597 |
| 86 | termination of RNA polymerase III transcription (GO:0006386) | 2.33822597 |
| 87 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.33117590 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 2.32978980 |
| 89 | microtubule depolymerization (GO:0007019) | 2.32188846 |
| 90 | gamma-aminobutyric acid transport (GO:0015812) | 2.31922560 |
| 91 | DNA double-strand break processing (GO:0000729) | 2.31683179 |
| 92 | mast cell degranulation (GO:0043303) | 2.31675847 |
| 93 | mast cell activation involved in immune response (GO:0002279) | 2.31675847 |
| 94 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.30316880 |
| 95 | epithelial cilium movement (GO:0003351) | 2.29855046 |
| 96 | anterograde axon cargo transport (GO:0008089) | 2.29753430 |
| 97 | negative regulation of catecholamine secretion (GO:0033604) | 2.29283508 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 2.29006300 |
| 99 | deoxyribonucleotide catabolic process (GO:0009264) | 2.28903639 |
| 100 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.28806043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.39684568 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.19464673 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.94674845 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.92181797 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.90287979 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.73759335 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.72120173 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.67241449 |
| 9 | EWS_26573619_Chip-Seq_HEK293_Human | 2.51428314 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.44943998 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.25690279 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.21222642 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17095192 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.10444927 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06626082 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.01807480 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 1.98682963 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93508675 |
| 19 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92063189 |
| 20 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.79229052 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77302773 |
| 22 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75509894 |
| 23 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.73211860 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72995711 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.70031704 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.68235646 |
| 27 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.67839257 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67461390 |
| 29 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.67156273 |
| 30 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.66785155 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.62538478 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59656452 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59034018 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55689932 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52062005 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47558737 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47027108 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47027108 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42161140 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40017443 |
| 41 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.37854767 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37634164 |
| 43 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.34694409 |
| 44 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.34694409 |
| 45 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.34152582 |
| 46 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.34152582 |
| 47 | AR_20517297_ChIP-Seq_VCAP_Human | 1.33526684 |
| 48 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31739327 |
| 49 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31535061 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31194136 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29407225 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27701852 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27400738 |
| 54 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23809845 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22583688 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22249820 |
| 57 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21969952 |
| 58 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.21807730 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20152096 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17855719 |
| 61 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17237046 |
| 62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16284895 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15488028 |
| 64 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.15344266 |
| 65 | NCOR_22424771_ChIP-Seq_293T_Human | 1.15085234 |
| 66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13861728 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13829135 |
| 68 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12989448 |
| 69 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12843319 |
| 70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11825906 |
| 71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10041278 |
| 72 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09653376 |
| 73 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07994093 |
| 74 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.06405950 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05757678 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05481743 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05076872 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03800376 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03755366 |
| 80 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.01870727 |
| 81 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01797179 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01662623 |
| 83 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00722016 |
| 84 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00602233 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98767331 |
| 86 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98764596 |
| 87 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98276857 |
| 88 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.98219319 |
| 89 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98111789 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98111789 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.98028786 |
| 92 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97965299 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97518358 |
| 94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96547524 |
| 95 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95730817 |
| 96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95495956 |
| 97 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95132365 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94908020 |
| 99 | JUN_21703547_ChIP-Seq_K562_Human | 0.94435405 |
| 100 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94423620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 3.95914303 |
| 2 | MP0010386_abnormal_urinary_bladder | 3.90189458 |
| 3 | MP0005084_abnormal_gallbladder_morpholo | 2.89213071 |
| 4 | MP0003283_abnormal_digestive_organ | 2.73695356 |
| 5 | MP0002735_abnormal_chemical_nociception | 2.68401179 |
| 6 | MP0005646_abnormal_pituitary_gland | 2.46998098 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 2.44974247 |
| 8 | MP0001986_abnormal_taste_sensitivity | 2.40316367 |
| 9 | MP0002653_abnormal_ependyma_morphology | 2.25836534 |
| 10 | MP0003724_increased_susceptibility_to | 2.20092681 |
| 11 | MP0000372_irregular_coat_pigmentation | 2.10030596 |
| 12 | MP0006072_abnormal_retinal_apoptosis | 2.00938184 |
| 13 | MP0008872_abnormal_physiological_respon | 1.98893634 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 1.97384115 |
| 15 | MP0002102_abnormal_ear_morphology | 1.88298265 |
| 16 | MP0003195_calcinosis | 1.83437009 |
| 17 | MP0004742_abnormal_vestibular_system | 1.81828885 |
| 18 | MP0004215_abnormal_myocardial_fiber | 1.81354142 |
| 19 | MP0005410_abnormal_fertilization | 1.78889305 |
| 20 | MP0009046_muscle_twitch | 1.74756583 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.74061934 |
| 22 | MP0000230_abnormal_systemic_arterial | 1.72931380 |
| 23 | MP0005671_abnormal_response_to | 1.71016725 |
| 24 | MP0002736_abnormal_nociception_after | 1.70257700 |
| 25 | MP0006276_abnormal_autonomic_nervous | 1.67652303 |
| 26 | MP0002272_abnormal_nervous_system | 1.63930572 |
| 27 | MP0001970_abnormal_pain_threshold | 1.60886452 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.59037575 |
| 29 | MP0001879_abnormal_lymphatic_vessel | 1.57017560 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.55755062 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.50021966 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.44386921 |
| 33 | MP0001905_abnormal_dopamine_level | 1.44032336 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.42749567 |
| 35 | MP0001486_abnormal_startle_reflex | 1.42730089 |
| 36 | MP0001756_abnormal_urination | 1.39103599 |
| 37 | MP0008004_abnormal_stomach_pH | 1.37697337 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.33626222 |
| 39 | MP0008775_abnormal_heart_ventricle | 1.30622301 |
| 40 | MP0002163_abnormal_gland_morphology | 1.29670443 |
| 41 | MP0009697_abnormal_copulation | 1.29149217 |
| 42 | MP0004147_increased_porphyrin_level | 1.27812637 |
| 43 | MP0009764_decreased_sensitivity_to | 1.22990535 |
| 44 | MP0004142_abnormal_muscle_tone | 1.21837011 |
| 45 | MP0009745_abnormal_behavioral_response | 1.20791828 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.19477968 |
| 47 | MP0003186_abnormal_redox_activity | 1.18810503 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.16116919 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.15203413 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.14922188 |
| 51 | MP0001984_abnormal_olfaction | 1.12658527 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.11222529 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.10390257 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.06967342 |
| 55 | MP0003638_abnormal_response/metabolism_ | 1.06595528 |
| 56 | MP0008877_abnormal_DNA_methylation | 1.06289753 |
| 57 | MP0005535_abnormal_body_temperature | 1.05889533 |
| 58 | MP0008058_abnormal_DNA_repair | 1.05786498 |
| 59 | MP0002693_abnormal_pancreas_physiology | 1.05762035 |
| 60 | MP0005253_abnormal_eye_physiology | 1.04839565 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.03573413 |
| 62 | MP0003011_delayed_dark_adaptation | 1.03494703 |
| 63 | MP0005332_abnormal_amino_acid | 1.03360254 |
| 64 | MP0003303_peritoneal_inflammation | 1.03014484 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.01724132 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.01545334 |
| 67 | MP0004134_abnormal_chest_morphology | 1.00634135 |
| 68 | MP0000538_abnormal_urinary_bladder | 1.00158472 |
| 69 | MP0002064_seizures | 0.99528496 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 0.99439058 |
| 71 | MP0004085_abnormal_heartbeat | 0.98731000 |
| 72 | MP0000343_altered_response_to | 0.98421637 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.96349075 |
| 74 | MP0003880_abnormal_central_pattern | 0.95049043 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 0.92878478 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 0.92218782 |
| 77 | MP0002067_abnormal_sensory_capabilities | 0.90546482 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.87771653 |
| 79 | MP0003718_maternal_effect | 0.84869584 |
| 80 | MP0002009_preneoplasia | 0.82885001 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.81608198 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.81224000 |
| 83 | MP0003866_abnormal_defecation | 0.80551290 |
| 84 | MP0001663_abnormal_digestive_system | 0.80361427 |
| 85 | MP0005448_abnormal_energy_balance | 0.78304455 |
| 86 | MP0006292_abnormal_olfactory_placode | 0.77139110 |
| 87 | MP0004885_abnormal_endolymph | 0.77028024 |
| 88 | MP0005266_abnormal_metabolism | 0.76842049 |
| 89 | MP0005000_abnormal_immune_tolerance | 0.75774697 |
| 90 | MP0001664_abnormal_digestion | 0.75685525 |
| 91 | MP0005389_reproductive_system_phenotype | 0.75090953 |
| 92 | MP0003787_abnormal_imprinting | 0.74009576 |
| 93 | MP0005365_abnormal_bile_salt | 0.73505473 |
| 94 | MP0002751_abnormal_autonomic_nervous | 0.72711107 |
| 95 | MP0005647_abnormal_sex_gland | 0.72135304 |
| 96 | MP0003635_abnormal_synaptic_transmissio | 0.70221283 |
| 97 | MP0010094_abnormal_chromosome_stability | 0.68707910 |
| 98 | MP0001188_hyperpigmentation | 0.68479247 |
| 99 | MP0001765_abnormal_ion_homeostasis | 0.66646459 |
| 100 | MP0005187_abnormal_penis_morphology | 0.66104982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.45322957 |
| 2 | Progressive macrocephaly (HP:0004481) | 4.15785266 |
| 3 | Prolonged bleeding time (HP:0003010) | 4.10511606 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.01002217 |
| 5 | Acute encephalopathy (HP:0006846) | 3.96182934 |
| 6 | 3-Methylglutaconic aciduria (HP:0003535) | 3.70998713 |
| 7 | Abolished electroretinogram (ERG) (HP:0000550) | 3.41240066 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.40024968 |
| 9 | Petechiae (HP:0000967) | 3.18396388 |
| 10 | Congenital, generalized hypertrichosis (HP:0004540) | 3.11792571 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 3.09573431 |
| 12 | Cerebral edema (HP:0002181) | 3.07690861 |
| 13 | Menorrhagia (HP:0000132) | 3.06378028 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.05735683 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 3.05735683 |
| 16 | Increased mean platelet volume (HP:0011877) | 2.97916798 |
| 17 | Increased CSF lactate (HP:0002490) | 2.97557431 |
| 18 | Nausea (HP:0002018) | 2.97349140 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.94399532 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.94399532 |
| 21 | Abnormality of midbrain morphology (HP:0002418) | 2.92512919 |
| 22 | Molar tooth sign on MRI (HP:0002419) | 2.92512919 |
| 23 | Abnormal ciliary motility (HP:0012262) | 2.90063826 |
| 24 | Generalized aminoaciduria (HP:0002909) | 2.86064186 |
| 25 | Hepatic necrosis (HP:0002605) | 2.83041606 |
| 26 | Pancreatic cysts (HP:0001737) | 2.82763103 |
| 27 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.78052303 |
| 28 | Aplastic anemia (HP:0001915) | 2.74705361 |
| 29 | Constricted visual fields (HP:0001133) | 2.71298965 |
| 30 | Abnormal platelet volume (HP:0011876) | 2.68506072 |
| 31 | Decreased central vision (HP:0007663) | 2.66587590 |
| 32 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.66577899 |
| 33 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.66577899 |
| 34 | Hepatocellular necrosis (HP:0001404) | 2.56304271 |
| 35 | Polyphagia (HP:0002591) | 2.51685958 |
| 36 | Pancreatic fibrosis (HP:0100732) | 2.49486907 |
| 37 | True hermaphroditism (HP:0010459) | 2.43119647 |
| 38 | Epistaxis (HP:0000421) | 2.39694668 |
| 39 | Optic disc pallor (HP:0000543) | 2.37131850 |
| 40 | Stomach cancer (HP:0012126) | 2.33827607 |
| 41 | Dyschromatopsia (HP:0007641) | 2.29371826 |
| 42 | Lactic acidosis (HP:0003128) | 2.28260480 |
| 43 | Purpura (HP:0000979) | 2.27273433 |
| 44 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.23957705 |
| 45 | Nephronophthisis (HP:0000090) | 2.23938925 |
| 46 | Attenuation of retinal blood vessels (HP:0007843) | 2.23669109 |
| 47 | Lethargy (HP:0001254) | 2.18394231 |
| 48 | Hypothermia (HP:0002045) | 2.17243239 |
| 49 | Abnormality of the renal cortex (HP:0011035) | 2.16329485 |
| 50 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.12778132 |
| 51 | Type 2 muscle fiber atrophy (HP:0003554) | 2.11537510 |
| 52 | Renal cortical cysts (HP:0000803) | 2.09826010 |
| 53 | Increased serum lactate (HP:0002151) | 2.08607287 |
| 54 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08570189 |
| 55 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08570189 |
| 56 | Exertional dyspnea (HP:0002875) | 2.07469933 |
| 57 | Abnormal drinking behavior (HP:0030082) | 2.06195136 |
| 58 | Polydipsia (HP:0001959) | 2.06195136 |
| 59 | Hyperglycinuria (HP:0003108) | 2.04774193 |
| 60 | Degeneration of anterior horn cells (HP:0002398) | 2.04027864 |
| 61 | Abnormality of the anterior horn cell (HP:0006802) | 2.04027864 |
| 62 | Impaired platelet aggregation (HP:0003540) | 2.00811158 |
| 63 | Abnormal platelet function (HP:0011869) | 2.00811158 |
| 64 | Renal Fanconi syndrome (HP:0001994) | 2.00803391 |
| 65 | Pendular nystagmus (HP:0012043) | 2.00008007 |
| 66 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98898305 |
| 67 | Respiratory failure (HP:0002878) | 1.97394836 |
| 68 | Increased hepatocellular lipid droplets (HP:0006565) | 1.97361305 |
| 69 | Hypomagnesemia (HP:0002917) | 1.95357170 |
| 70 | Ulnar claw (HP:0001178) | 1.93499666 |
| 71 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90705311 |
| 72 | Abnormality of alanine metabolism (HP:0010916) | 1.90705311 |
| 73 | Hyperalaninemia (HP:0003348) | 1.90705311 |
| 74 | Leukodystrophy (HP:0002415) | 1.90522817 |
| 75 | Type I transferrin isoform profile (HP:0003642) | 1.83380267 |
| 76 | Hyperglycinemia (HP:0002154) | 1.82675819 |
| 77 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.82636849 |
| 78 | Stomatitis (HP:0010280) | 1.82505699 |
| 79 | Hemiparesis (HP:0001269) | 1.82117033 |
| 80 | Lipid accumulation in hepatocytes (HP:0006561) | 1.80889696 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 1.80324892 |
| 82 | Focal motor seizures (HP:0011153) | 1.79470265 |
| 83 | Abnormality of the renal medulla (HP:0100957) | 1.79309940 |
| 84 | Congenital stationary night blindness (HP:0007642) | 1.77581090 |
| 85 | Polyuria (HP:0000103) | 1.76548652 |
| 86 | Fair hair (HP:0002286) | 1.75715275 |
| 87 | Lissencephaly (HP:0001339) | 1.74440533 |
| 88 | Pancytopenia (HP:0001876) | 1.73582795 |
| 89 | Biliary tract neoplasm (HP:0100574) | 1.73057203 |
| 90 | Abnormality of urine glucose concentration (HP:0011016) | 1.72120498 |
| 91 | Glycosuria (HP:0003076) | 1.72120498 |
| 92 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.71707629 |
| 93 | Abnormality of the prostate (HP:0008775) | 1.67623580 |
| 94 | Intestinal atresia (HP:0011100) | 1.67402702 |
| 95 | Muscle fiber atrophy (HP:0100295) | 1.67049276 |
| 96 | Hypoplasia of the fovea (HP:0007750) | 1.66831295 |
| 97 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.66831295 |
| 98 | Exercise intolerance (HP:0003546) | 1.66381402 |
| 99 | Abnormal pupillary function (HP:0007686) | 1.66075040 |
| 100 | Increased intramyocellular lipid droplets (HP:0012240) | 1.65891235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.84958064 |
| 2 | MST4 | 3.88689169 |
| 3 | WNK3 | 3.00022310 |
| 4 | ZAK | 2.68043616 |
| 5 | FRK | 2.50779965 |
| 6 | TIE1 | 2.49206781 |
| 7 | ADRBK2 | 2.42935020 |
| 8 | OXSR1 | 2.09979942 |
| 9 | TEC | 1.91715125 |
| 10 | TXK | 1.84587495 |
| 11 | TAOK3 | 1.83523518 |
| 12 | GRK1 | 1.83395842 |
| 13 | EIF2AK1 | 1.78169307 |
| 14 | MYLK | 1.76417137 |
| 15 | MAP4K2 | 1.73234512 |
| 16 | FES | 1.72486121 |
| 17 | VRK2 | 1.71858051 |
| 18 | KIT | 1.69999017 |
| 19 | BMPR1B | 1.69463663 |
| 20 | NUAK1 | 1.67904029 |
| 21 | STK39 | 1.57286158 |
| 22 | MAPK13 | 1.46135829 |
| 23 | IRAK1 | 1.39399031 |
| 24 | BCKDK | 1.33596319 |
| 25 | DYRK2 | 1.31356587 |
| 26 | MAP3K4 | 1.26347703 |
| 27 | TLK1 | 1.21536659 |
| 28 | DAPK1 | 1.18897699 |
| 29 | SYK | 1.16343291 |
| 30 | VRK1 | 1.11413295 |
| 31 | DAPK2 | 1.07696623 |
| 32 | PIK3CG | 1.04765885 |
| 33 | PLK3 | 1.03903317 |
| 34 | INSRR | 1.01722951 |
| 35 | MATK | 1.01637316 |
| 36 | PTK2B | 1.00129035 |
| 37 | RIPK4 | 0.99905594 |
| 38 | ADRBK1 | 0.99665040 |
| 39 | EIF2AK3 | 0.97605561 |
| 40 | WNK4 | 0.96788521 |
| 41 | GRK5 | 0.92959265 |
| 42 | CSF1R | 0.91668525 |
| 43 | BTK | 0.90733208 |
| 44 | EPHA3 | 0.89293437 |
| 45 | MAPKAPK3 | 0.88442301 |
| 46 | MINK1 | 0.86096520 |
| 47 | IKBKB | 0.85768089 |
| 48 | ITK | 0.85205462 |
| 49 | PLK4 | 0.78836695 |
| 50 | NEK1 | 0.78432957 |
| 51 | PNCK | 0.76038490 |
| 52 | CDK8 | 0.73622753 |
| 53 | CSNK1G1 | 0.72218427 |
| 54 | LYN | 0.71693469 |
| 55 | TRIM28 | 0.71379744 |
| 56 | PHKG1 | 0.71053726 |
| 57 | PHKG2 | 0.71053726 |
| 58 | FER | 0.70736770 |
| 59 | CSNK1G2 | 0.70554823 |
| 60 | BMX | 0.70275328 |
| 61 | BCR | 0.68422901 |
| 62 | NLK | 0.68290590 |
| 63 | MAP2K4 | 0.66851571 |
| 64 | PRKCE | 0.64951804 |
| 65 | CSNK1G3 | 0.64235508 |
| 66 | NEK2 | 0.59265451 |
| 67 | MAP2K7 | 0.59183291 |
| 68 | ILK | 0.59039788 |
| 69 | MKNK1 | 0.58099287 |
| 70 | ACVR1B | 0.56778217 |
| 71 | PLK2 | 0.56626545 |
| 72 | DAPK3 | 0.56093215 |
| 73 | PRKCQ | 0.55195751 |
| 74 | NTRK3 | 0.53493418 |
| 75 | ERBB3 | 0.53362893 |
| 76 | PRKCG | 0.53221520 |
| 77 | TNK2 | 0.53094017 |
| 78 | CHEK2 | 0.52633869 |
| 79 | LMTK2 | 0.52264774 |
| 80 | PASK | 0.51406303 |
| 81 | GRK7 | 0.49638784 |
| 82 | MAP3K11 | 0.48063042 |
| 83 | MKNK2 | 0.47150871 |
| 84 | MARK1 | 0.46642909 |
| 85 | HCK | 0.46168307 |
| 86 | CAMKK2 | 0.45957685 |
| 87 | TSSK6 | 0.45401950 |
| 88 | PINK1 | 0.45359889 |
| 89 | IRAK2 | 0.45285850 |
| 90 | BRSK2 | 0.44466685 |
| 91 | GRK6 | 0.42782247 |
| 92 | IGF1R | 0.42669821 |
| 93 | MAP3K5 | 0.42519629 |
| 94 | PAK3 | 0.41899583 |
| 95 | ABL2 | 0.40598032 |
| 96 | IKBKE | 0.40018956 |
| 97 | STK16 | 0.39569346 |
| 98 | PRKCA | 0.38741752 |
| 99 | CAMK2A | 0.38617640 |
| 100 | PRKG1 | 0.38447386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.93588247 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.42727753 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.45007558 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.23026715 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.18736075 |
| 6 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.03457003 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.01432458 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 1.99012352 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86546647 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.79959244 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.78352859 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.73855996 |
| 13 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.72525112 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.71407671 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.70857351 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.69627747 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.69522965 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.68990783 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.68183504 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57996670 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.53273692 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.53195146 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.51773760 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.49084330 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.48608513 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46820831 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36746387 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.35062973 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.32428003 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.30143267 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.27466772 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26056200 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25873723 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23353272 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23029129 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.23026678 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21506165 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21403268 |
| 39 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.18610370 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16655635 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13573107 |
| 42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.10902815 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09883820 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.08739195 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.08332722 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 1.05517949 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05172138 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04687692 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04526262 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04440854 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03506150 |
| 52 | Taste transduction_Homo sapiens_hsa04742 | 1.03217653 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.02538599 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96854541 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94989629 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 0.94500385 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94095873 |
| 58 | Base excision repair_Homo sapiens_hsa03410 | 0.94046167 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89782527 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88291555 |
| 61 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86776071 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.84178074 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84024104 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82048370 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81606289 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81395183 |
| 67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78335346 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76665884 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76595889 |
| 70 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.74950768 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73984237 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73652503 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72395807 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72043393 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70243838 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69702145 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69278610 |
| 78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.68609057 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67970705 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66956574 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64927918 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64771194 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63933772 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63219497 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60845167 |
| 86 | DNA replication_Homo sapiens_hsa03030 | 0.58260540 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58210634 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.56186096 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55981229 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.54675178 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.51226809 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51020059 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48610545 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46209733 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44748976 |
| 96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44325696 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43385074 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37634275 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37307452 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37031959 |

